Response | Visits | Robenacoxib (s.c. + oral) | Meloxicam s.c. + oral placebo | P value (Mann–Whitney test) | Quotient robenacoxib:meloxicam (RMANCOVA) | P value (RMANCOVA) | Transformation for RMANCOVA analysis | ||
---|---|---|---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Mean | 95% CI | Exponential | P value for normality (Shapiro-Wilks test) | ||||
Level of activity | D1-VF | 0.62 (0.53) | 0.64 (0.61) | 0.96 | 0.972 | 0.658–1.373 | 0.87 | 0 (log) | <0.0001 |
Behaviour | D1-VF | 0.29 (0.38) | 0.31 (0.34) | 0.57 | 1.285 | 0.731–2.240 | 0.34 | −1 (reciprocal) | <0.0001 |
Appetite | D1-VF | 0.38 (0.48) | 0.37 (0.49) | 0.69 | 1.006 | 0.551–1.672 | 0.98 | −1 (reciprocal) | <0.0001 |
Interaction | D1-VF | 0.23 (0.34) | 0.26 (0.33) | 0.70 | 1.306 | 0.696–2.452 | 0.36 | −1 (reciprocal) | <0.0001 |
Global owner score | D1-VF | 1.52 (1.42) | 1.58 (1.45) | 0.87 | 1.050 | 0.719–1.482 | 0.78 | 0 (log) | <0.0001 |